GlassScriptPhysician profile
Sara Pope Ruiz
NPI 1578891420
$4,192.93
in general payments reported to CMS, 2019-2025
27 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.61 · 2020: $289 · 2021: $900 · 2022: $634 · 2023: $600 · 2024: $325 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,292.48 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2025 | |
| Abbvie INC. | $712.15 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Pfizer INC. | $254.11 | 2019-2024 | |
| Daiichi Sankyo INC. | $253.61 | 2019-2025 | Injectafer |
| Mayne Pharma Commercial LLC | $245.72 | 2022-2025 | |
| Minerva Surgical, INC | $239.24 | 2021 | |
| Exeltis, USA INC. | $184.43 | 2020-2025 | Slynd |
| Sumitomo Pharma America, INC. | $177.25 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $170.72 | 2020-2024 | Veozah |
| Sage Therapeutics, LLC | $135.07 | 2021-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $109.96 | 2020-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Therapeuticsmd, INC. | $91.51 | 2020-2021 | |
| Millicent US INC | $88.78 | 2025 | Intrarosa, Femring, Femlyv |
| Myovant Sciences INC. | $78.83 | 2021-2022 | |
| Organon LLC | $71.44 | 2022-2025 | Nexplanon |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $57.39 | 2019-2021 | |
| Coopersurgical, INC. | $47.79 | 2019-2023 | Endosee |
| Optumhealth Care Solutions, LLC | $41.64 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Agile Therapeutics, INC. | $36.06 | 2021-2022 | |
| Avion Pharmaceuticals | $34.33 | 2021-2022 | |
| Scynexis, INC. | $34.29 | 2022 | |
| Shield Therapeutics INC | $28.14 | 2024-2025 | |
| Amag Pharmaceuticals, INC. | $24.25 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $24.24 | 2025 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $23.57 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $17.28 | 2021 | |
| Aspira Women'S Health INC | $11.13 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.